Publications


Seavey, C. N., Hallett, A., Li, S., Che, K., Pobbati, A. V., Ma, S., Burtscher, A., Kanai, R., Lamar, J. M., Rubin, B. P. Loss of CDKN2A cooperates with WWTR1(TAZ)-CAMTA1 gene fusion to promote tumor progression in epithelioid hemangioendothelioma Clin Cancer Res., 2023, Epub ahead of print. PMID: 36598859


Thiemann RF, Varney S, Moskwa N, Lamar J, Larsen M, LaFlamme SE. Regulation of myoepithelial differentiation. PLoS One, 2022;17(5):e0268668. PMC9135247.

 

Mohammadalipour, A.; Diaz, M.F.; Livingston, M.; Ewere, A.; Zhou, A.; Horton, P.D.; Olamigoke,L.T.; Lamar, J.M.; Hagan, J.P.; Lee, H.J.; Wenzel, P.L.  RhoAROCK competes with YAP to regulate amoeboid breast cancer cell migration in response to lymphaticlike flow FASEB Bioadv. 2022;4(5):342-61. PMC9065582

 

Ma S.; Kanai R.; Pobbati A.V.; Li S.; Che K.; Seavey C.N.; Hallett A.; Burtscher A.; Lamar J.M.; Rubin B.P. The TAZ-CAMTA1 fusion protein promotes tumorigenesis via connective tissue growth factor and Ras-MAPK signaling in epithelioid hemangioendothelioma. Clin Cancer Res., 2022, Epub ahead of print. PMC9306355


Sadhu, S.; Decker, C.; Sansbury, B.E.; Marinello, M.; Seyfried, A.; Howard, J.; Mori, M.; Hosseini, Z.,; Arunachalam, T.; Finn, A.V.; Lamar, J.M.; Jourd'heuil, D.; Guo, L.; MacNamara, K.C.; Spite, M.; Fredman, G.  Radiation-Induced Macrophage Senescence Impairs Resolution Programs and Drives Cardiovascular Inflammation. J Immunol, 2021, 207(7), 1812-1823. PMC8555670 


Kenney, J.; Ndoye, A.; Lamar, J.M.; DiPersio, C.M. Comparative use of CRISPR and RNAi to modulate integrin alpha3beta1 in triple negative breast cancer cells reveals that some pro-invasive/pro-metastatic alpha3beta1 functions are independent of global regulation of the transcriptome. PLoS One, 2021, 16(7), e0254714. PMC8284828

 

Seavey C.N.; Pobbati A.V.; Hallett A.; Ma S.;Reynolds J.P.;Kanai R.; Lamar J.M.; Rubin B.P. WWTR1(TAZ)-CAMTA1 gene fusion is sufficient to dysregulate YAP/TAZ signaling and drive epithelioid hemangioendothelioma tumorigenesis. Genes Dev. 2021 Apr 1;35(7-8):512-527 (Epub) PMC8015722

 

Miskin, R.P.; Warren, J.S.A.; Ndoye, A.; Wu, L.; Lamar, J.M.; DiPersio, C.M. Integrin alpha3beta1 promotes invasive and metastatic properties of breast cancer cells through induction of the brn-2 transcription factor. Cancers (Basel) 2021, 13. PMC7866210


Lu, Y.W.; Martino, N.; Gerlach, B.D.; Lamar, J.M.; Vincent, P.A.; Adam, A.P.; Schwarz, J.J. Mef2 (myocyte enhancer factor 2) is essential for endothelial homeostasis and the atheroprotective gene expression program. Arterioscler Thromb Vasc Biol 2021, 41, 1105-1123. PMC7938420

 

Benjamin, D.C.; Kang, J.H.; Hamza, B.; King, E.M.; Lamar, J.M.; Manalis, S.R.; Hynes, R.O. Yap enhances tumor cell dissemination by promoting intravascular motility and reentry into systemic circulation. Cancer Res 2020, 80, 3867-3879. PMC7501173

 

Xiao, Y.; Lamar, J.M. Identification of transcription factor regulators using medium-throughput screening of arrayed libraries and a dual-luciferase-based reporter. J Vis Exp 2020. PMID:32281984

 

Tubbesing, K.; Ward, J.; Abini-Agbomson, R.; Malhotra, A.; Rudkouskaya, A.; Warren, J.; Lamar, J.; Martino, N.; Adam, A.P.; Barroso, M. Complex rab4-mediated regulation of endosomal size and egfr activation. Mol Cancer Res 2020, 18, 757-773. PMC7526990

 

Hebert, J.D.; Tian, C.; Lamar, J.M.; Rickelt, S.; Abbruzzese, G.; Liu, X.; Hynes, R.O. The scaffold protein iqgap1 is crucial for extravasation and metastasis. Sci Rep 2020, 10, 2439. PMC7015931

 

Hebert, J.D.; Myers, S.A.; Naba, A.; Abbruzzese, G.; Lamar, J.M.; Carr, S.A.; Hynes, R.O. Proteomic profiling of the ecm of xenograft breast cancer metastases in different organs reveals distinct metastatic niches. Cancer Res 2020, 80, 1475-1485. PMC7127975


Warren, J.S.A.; Feustel, P.J.; Lamar, J.M. Combined use of tail vein metastasis assays and real-time in vivo imaging to quantify breast cancer metastatic colonization and burden in the lungs. J Vis Exp 2019. PMID:31904024

 

Lamar, J.M.; Xiao, Y.; Norton, E.; Jiang, Z.-G.; Gerhard, G.M.; Kooner, S.; Warren, J.S.A.; Hynes, R.O. Src tyrosine kinase activates the yap/taz axis and thereby drives tumor growth and metastasis. Journal of Biological Chemistry 2019, 294, 2302-2317. PMC6378979 * Selected for Special Issue

 

Kanai, R.; Lamar, J.M. Taz teases t cells with pd-l1. Gland Surg 2019, 8, 322-326. PMC6723008

 

Warren, J.S.A.; Xiao, Y.; Lamar, J.M. Yap/taz activation as a target for treating metastatic cancer. Cancers (Basel) 2018, 10. PMC5923370 * Featured paper and Editors Choice

 

Steigedal, T.S.; Toraskar, J.; Redvers, R.P.; Valla, M.; Magnussen, S.N.; Bofin, A.M.; Opdahl, S.; Lundgren, S.; Eckhardt, B.L.; Lamar, J.M.; Doherty, J.; Hynes, R.O.; Anderson, R.L.; Svineng, G. Nephronectin is correlated with poor prognosis in breast cancer and promotes metastasis via its integrin-binding motifs. Neoplasia 2018, 20, 387-400. PMC5909680

 

Lamar, J.M.; Motilal Nehru, V.; Weinberg, G. Epithelioid hemangioendothelioma as a model of yap/taz-driven cancer: Insights from a rare fusion sarcoma. Cancers (Basel) 2018, 10. PMC6070876 * Feautred paper

 

Kulkarni, M.; Tan, T.Z.; Syed Sulaiman, N.B.; Lamar, J.M.; Bansal, P.; Cui, J.; Qiao, Y.; Ito, Y. Runx1 and runx3 protect against yap-mediated emt, stem-ness and shorter survival outcomes in breast cancer. Oncotarget 2018, 9, 14175-14192. PMC5865662

 

Oudin, M.J.; Jonas, O.; Kosciuk, T.; Broye, L.C.; Guido, B.C.; Wyckoff, J.; Riquelme, D.; Lamar, J.M.; Asokan, S.B.; Whittaker, C.; Ma, D.; Langer, R.; Cima, M.J.; Wisinski, K.B.; Hynes, R.O.; Lauffenburger, D.A.; Keely, P.J.; Bear, J.E.; Gertler, F.B. Tumor cell-driven extracellular matrix remodeling drives haptotaxis during metastatic progression. Cancer Discov 2016, 6, 516-531. PMC4854754 

 

Chen, M.B.; Lamar, J.M.; Li, R.; Hynes, R.O.; Kamm, R.D. Elucidation of the roles of tumor integrin beta1 in the extravasation stage of the metastasis cascade. Cancer Res 2016, 76, 2513-2524. PMC4873393 

 

Naba, A.; Clauser, K.R.; Lamar, J.M.; Carr, S.A.; Hynes, R.O. Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters. eLife 2014, 3, e01308. PMC3944437

 

Wang, X.; Lu, H.; Urvalek, A.M.; Li, T.; Yu, L.; Lamar, J.; DiPersio, C.M.; Feustel, P.J.; Zhao, J. Klf8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of mmp9. Oncogene 2010, 30, 1901-1911. PMC3952074

 

Reticker-Flynn, N.E.; Malta, D.F.B.; Winslow, M.M.; Lamar, J.M.; Xu, M.J.; Underhill, G.H.; Hynes, R.O.; Jacks, T.E.; Bhatia, S.N. A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis. Nat Commun 2012, 3, 1122. PMC3794716

 

Lamar, J.M.; Stern, P.; Liu, H.; Schindler, J.W.; Jiang, Z.G.; Hynes, R.O. The hippo pathway target, yap, promotes metastasis through its tead-interaction domain. Proc Natl Acad Sci U S A 2012, 109, E2441-2450. PMC3443162

 

Lamar, J.; DiPersio, C.M. Roles of integrins in the development and progression of squamous cell carcinomas. In Signaling pathways in squamous cancer, Glick, A.B.; Waes, C.V., Eds. Springer New York: 2011; pp 21-52.

 

da Silva, R.G.; Tavora, B.; Robinson, S.D.; Reynolds, L.E.; Szekeres, C.; Lamar, J.; Batista, S.; Kostourou, V.; Germain, M.A.; Reynolds, A.R.; Jones, D.T.; Watson, A.R.; Jones, J.L.; Harris, A.; Hart, I.R.; Iruela-Arispe, M.L.; Dipersio, C.M.; Kreidberg, J.A.; Hodivala-Dilke, K.M. Endothelial alpha3beta1-integrin represses pathological angiogenesis and sustains endothelial-vegf. Am J Pathol 2010, 177, 1534-1548. PMC2928983

 

Lamar, J.M.; Pumiglia, K.M.; DiPersio, C.M. An immortalization-dependent switch in integrin function up-regulates mmp-9 to enhance tumor cell invasion. Cancer Res 2008, 68, 7371-7379. PMC2782775

 

Lamar, J.M.; Iyer, V.; DiPersio, C.M. Integrin alpha3beta1 potentiates tgfbeta-mediated induction of mmp-9 in immortalized keratinocytes. J Invest Dermatol 2008, 128, 575-586. PMC2709505

 

Manohar, A.; Shome, S.G.; Lamar, J.; Stirling, L.; Iyer, V.; Pumiglia, K.; DiPersio, C.M. Alpha 3 beta 1 integrin promotes keratinocyte cell survival through activation of a mek/erk signaling pathway. J Cell Sci 2004, 117, 4043-4054. PMID:31904024